drugset / Trial / NCT02456688

Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency

NCT02456688 ↗

Phase 1 Unknown 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This clinical research study will assess pharmacokinetics and the safety of Imrecoxib in patients with impaired hepatic function as compared to healthy volunteers.

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Imrecoxib Small molecule — —

Indications